Related Experiment Video
Updated: Jan 18, 2026

Quantitative Structure-Activity Relationship, Activity Prediction, and Molecular Dynamics of Non-nucleotide Reverse Transcriptase Inhibitors
Published on: May 9, 2025
[HIV in 2025 : innovations, persistent vulnerabilities, and a future under strain].
Olivier Nawej Tshikung1, Olivier Segeral1, Alexandra Calmy1
1Unité VIH/Sida, Service des maladies infectieuses, Hôpitaux universitaires de Genève, 1211 Genève 14.
Advances in HIV prevention and treatment are now WHO guidelines, but many patients still start care late. Reduced funding threatens HIV programs, risking progress toward 2030 targets.
Area of Science:
- Global Health
- Infectious Diseases
- Public Health Policy
Related Concept Videos
Viral Mutations
Issues And Trends In Healthcare Delivery System
Cost Containment
Payment for healthcare services has historically promoted adoption of costly and often unnecessary or inefficient...
Retrovirus Life Cycles
Microorganisms in Medicine and Therapeutics
Sexually Transmitted Infections
Healthcare Associated Infections II: Preventive Measures
The best practices for preventing healthcare-associated infections include hand hygiene, patient risk...

